“…Collectively, we identified in silico several biologically relevant parameters of PFKL (i.e., its intermolecular interaction strength, its effective concentration, its multivalency, and its pre-organization prior to condensate formation) that would regulate the formation of PFKL condensates and their sizes in cells. Accordingly, we propose that, when the scaffolder enzyme of a multienzyme glucosome condensate, PFKL, is subcellularly controlled to present relatively a stronger interaction or a higher effective concentration, regulated to be located in a higher multivalency mimicking environment, or organized to form filamentous or similar structures in a cell, the formation of glucosome condensates would be promoted to orchestrate glucose flux in conjunction with other cellular processes in human cells (Jeon et al ., 2022a; Jeon et al ., 2018; Jeon et al ., 2022b; Kennedy et al ., 2022; Kohnhorst et al ., 2017). Considering our study was done in silico with stochastic modeling approaches, we offer a possibility that any metabolic enzymes might be able to form spatially resolved condensates, but at different degrees, in human cells particularly when their biological and physical properties are perturbed acutely and/or dysregulated chronically in human cells.…”